Inherited and Rare Cardiovascular Diseases Unit, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Monaldi Hospital, Via Leonardo Bianchi 1, 80131, Naples, Italy.
Inherited and Rare Cardiovascular Diseases Unit, Department of Translational Medical Sciences, University of Campania "Luigi Vanvitelli", Monaldi Hospital, Via Leonardo Bianchi 1, 80131, Naples, Italy; Institute of Cardiovascular Sciences, University College of London and St. Bartholomew's Hospital, Grower Street, London WC1E 6DD, UK; Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart, Italy.
Heart Fail Clin. 2021 Oct;17(4):673-683. doi: 10.1016/j.hfc.2021.05.011. Epub 2021 Jul 22.
Heart failure (HF) is an important health care issue in children because of its considerable morbidity and mortality. Advanced HF encompasses patients who remained symptomatic despite optimal medical treatment and includes patients who require special management, such as continuous inotropic therapy, mechanical circulatory support, or heart transplantation (HT). HT is the gold standard for children with advanced HF; nonetheless, the number of suitable donors has not increased for decades, leading to prolonged waitlist times and increased mortality rates. Therefore, the role of pediatric mechanic circulatory support has been assessed as an alternative treatment in patients in whom heart transplant could not be performed. The authors discuss the epidemiology, causes, pathophysiology, clinical manifestation, medical treatment, device therapy, and HT in pediatric HF, and a particular emphasis was posed on patients with advanced HF.
心力衰竭(HF)是儿童的一个重要医疗保健问题,因为它具有相当高的发病率和死亡率。晚期 HF 包括尽管接受了最佳药物治疗仍有症状的患者,以及需要特殊管理的患者,例如持续正性肌力治疗、机械循环支持或心脏移植(HT)。HT 是晚期 HF 儿童的金标准;然而,数十年来合适供体的数量并未增加,导致等待名单时间延长和死亡率增加。因此,在无法进行心脏移植的患者中,儿科机械循环支持的作用已被评估为一种替代治疗方法。作者讨论了儿科 HF 的流行病学、病因、病理生理学、临床表现、药物治疗、器械治疗和 HT,并特别强调了晚期 HF 患者。